[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346249-105":59,"doc-detail-346249-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","identifying-a-recurrent-brca1-variant-in-the-qatari-population-with-unique-genotypephenotype-correlations","Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype—Phenotype Correlations","","Hereditary breast and ovarian cancer syndrome (HBOC) driven by pathogenic BRCA1 and BRCA2 variants is highly prevalent in Qatar, yet recurrent BRCA1 founder-like variants with clear genotype–phenotype patterns have not been well characterized. This retrospective study reviews Qatari patients with and without breast/ovarian cancer who carry pathogenic/likely pathogenic BRCA1 variants (2013–2020). Frequencies, clinical and tumor characteristics, family histories, and survival comparisons using Kaplan–Meier and log-rank analyses identify a highly recurrent BRCA1 variant strongly linked to early-onset triple-negative invasive ductal carcinoma.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identifying-a-recurrent-brca1-variant-in-the-qatari-population-with-unique-genotypephenotype-correlations/346249/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identifying-a-recurrent-brca1-variant-in-the-qatari-population-with-unique-genotypephenotype-correlations/346249.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main goal regarding BRCA1 in Qatar?","Question",{"text":113,"@type":114},"To describe a common recurrent pathogenic BRCA1 variant observed in the native Qatari population and to characterize its unique genotype–phenotype correlations.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What data were analyzed in the retrospective study?",{"text":118,"@type":114},"Medical records of Qatari patients with personal and/or family histories of breast and ovarian cancers who carry pathogenic/likely pathogenic BRCA1 variants were reviewed, including epidemiological and clinical variables and tumor characteristics.",{"name":120,"@type":111,"acceptedAnswer":121},"Which recurrent BRCA1 variant showed the strongest association, and with what cancer features?",{"text":122,"@type":114},"The BRCA1 c.4787C>A p.(Ser1596Ter) variant was highly recurrent and strongly associated with early-onset breast cancer, particularly invasive ductal carcinoma triple-negative breast cancer, rather than ovarian cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346249,1790116485,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Molecular Genetics & Genomic Medicine  \nORIGINAL ARTICLE  OPEN ACCESS   \nIdentifying a Recurrent BRCA1 Variant in the Qatari  \nPopulation With Unique Genotype—Phenotype Correlations  \nSalha Bujassoum Al-Bader1 | Hajer Al-Mulla1,2  | Hind Al-Habish1  | Sitti Kusasi1 | Nema Abduo1 | Nawal Bakheet1 | Hafedh Ghazouani1 | Mariem Sidenna1,2 | Fatemeh Abbaszadeh3 | Reem Alsulaiman1,2  \n1National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar | 2Department of Medical Genetics, Hamad Medical  \nCorporation, Doha, Qatar | 3Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar Correspondence: Salha Bujassoum Al-Bader ([sbujassoum@hamad.qa](sbujassoum@hamad.qa))  \nReceived: 15 August 2024 | Revised: 25 May 2025 | Accepted: 8 September 2025  \nFunding: This work was supported by Hamad Medical Corporation.  \nKeywords: BRCA1 | breast cancer | genotype–phenotype correlations | Qatari native population | recurrent variant  \nABSTRACT  \nBackground: Hereditary breast and ovarian cancer syndrome (HBOC) is the most common cause of hereditary breast and ovarian cancers in Qatar and worldwide, which is caused by pathogenic variants in the BRCA1 and BRCA2 genes. The aim of this retrospective study is to describe a common recurrent pathogenic variant in the BRCA1 gene that was observed in the native Qatari population with unique genotype–phenotype correlations.  \nMethods: Medical records of Qatari patients (affected and unaffected) with personal and/or family history of breast and ovarian cancers who carry pathogenic/likely pathogenic variants in the BRCA1 gene were reviewed between 2013 and 2020. Epidemiological information and clinical data were reviewed, including age, gender, ethnic background, personal history of cancer, tumour characteristics, and family history. We used frequencies and proportions to describe the data and used Kaplan–Meier curves and log-rank analysis to compare survival rates. For the analysis, we used Stata Corp. 2015. Stata Statistical Software: Release 14, College Station, TX: Stata Corp. LP.  \nEthical Compliance: Ethical committee approval was obtained from Hamad Medical Corporation IRB committee (MRC-01-20-1086) .  \nResult: Sixty-three Qatari affected patients and unaffected individuals who carry the BRCA1 variant were included in the study. Our result confirms the presence of a common recurrent pathogenic variant c.4787C>A p.(Ser1596Ter) among Qatari patients who belong to 8 consanguineous large families, followed by c.4065 _ 4068del p.Asn1355fs, both in BRCA1. The BRCA1 c.4787C>A variant is highly associated with early onset breast cancer, specifically invasive ductal carcinoma (IDC) triple negative breast cancer (stage I, grade III), rather than ovarian cancer. Additionally, the c.4787C>A variant was found to exhibit high penetrance in families with early-onset breast cancer.  \nConclusion: We showed that BRCA1 c.4787C>A pathogenic variant is a highly recurrent variant among Qatari consanguineous families and contributes to the early onset breast cancer in Qatar. Early identification of this variant can aid in improving patients' survival and guide early personalized treatment and prevention.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2026 The Author(s). Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.  \nMolecular Genetics & Genomic Medicine, 2026; 14:e70144 1 of 9  \n[https://doi.org/10.1002/mgg3.70144](https://doi.org/10.1002/mgg3.70144)  \n1 | Introduction  \nHereditary breast and ovarian cancer syndrome (HBOC) is a cancer predisposing syndrome caused by pathogenic variants in the BRCA1 and BRCA2 genes. It is associated with an increased risk for female breast and ovarian cancers and male breast","cbCaigXG2b4AnGBN","https://ap.wps.com/l/cbCaigXG2b4AnGBN","pdf",609460,"English","# ABSTRACT\n## Background\n## Methods\n## Result\n## Conclusion\n# Introduction","[{\"question\":\"What is the study’s main goal regarding BRCA1 in Qatar?\",\"answer\":\"To describe a common recurrent pathogenic BRCA1 variant observed in the native Qatari population and to characterize its unique genotype–phenotype correlations.\"},{\"question\":\"What data were analyzed in the retrospective study?\",\"answer\":\"Medical records of Qatari patients with personal and/or family histories of breast and ovarian cancers who carry pathogenic/likely pathogenic BRCA1 variants were reviewed, including epidemiological and clinical variables and tumor characteristics.\"},{\"question\":\"Which recurrent BRCA1 variant showed the strongest association, and with what cancer features?\",\"answer\":\"The BRCA1 c.4787C\\u003eA p.(Ser1596Ter) variant was highly recurrent and strongly associated with early-onset breast cancer, particularly invasive ductal carcinoma triple-negative breast cancer, rather than ovarian cancer.\"}]","Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype—Phenotype Correlations | PDF",1790060640,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2d615ce78d13cd6c477af87d8b7ab8d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed59fcd89c5f16934a5a64e60d36c8c2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7acca85c5156ee5544de57cc1725eb08.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cd5c8ada947f6af5a55143fdb7ca301.webp",980,1287]